$CTM stock is up 14% today. Here's what we see in our data.

$CTM stock has now risen 14% today, according to our price data from Polygon. There has been approximately $3,211,750 of trading volume.

$CTM Insider Trading Activity

$CTM insiders have traded $CTM stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $CTM stock by insiders over the last 6 months:

• MARK C FULLER has made 0 purchases and 3 sales selling 1,000,000 shares for an estimated $1,234,275.
• JAY O WRIGHT (General Counsel, Secretary) has made 0 purchases and 3 sales selling 759,400 shares for an estimated $995,008.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CTM Hedge Fund Activity

We have seen 18 institutional investors add shares of $CTM stock to their portfolio, and 11 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• ARMISTICE CAPITAL, LLC removed 1,535,505 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $1,627,635
• BANK OF NEW YORK MELLON CORP removed 627,822 shares (-51.1%) from their portfolio in Q1 2025, for an estimated $665,491
• VANGUARD GROUP INC added 555,687 shares (+662.0%) to their portfolio in Q1 2025, for an estimated $589,028
• JANE STREET GROUP, LLC removed 449,001 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $475,941
• MAGNUS FINANCIAL GROUP LLC removed 250,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $265,000
• INSCRIPTION CAPITAL, LLC added 237,500 shares (+1900.0%) to their portfolio in Q1 2025, for an estimated $251,750
• BLACKROCK, INC. added 127,421 shares (+inf%) to their portfolio in Q1 2025, for an estimated $135,066

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

You can track data on $CTM on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.